Keyphrases
Robotic Partial Nephrectomy
72%
Radical Retropubic Prostatectomy
31%
Renal Cell Carcinoma
27%
Prostate
26%
Estimated Glomerular Filtration Rate
22%
Robot-assisted
21%
Oncological Outcomes
18%
Small Renal Mass
17%
Robotics
16%
Partial Nephrectomy
16%
Robot-assisted Partial Nephrectomy
15%
Cystoscopy
14%
Radical Prostatectomy
14%
Functional Outcome
14%
Ureter
13%
Operative Time
13%
Bladder Neck
12%
Shock Wave Lithotripsy
12%
Single Center
12%
Surgical Outcomes
11%
Tumor Size
11%
Cadaver Model
11%
Renal Function
10%
Comparative Analysis
10%
Heminephrectomy
10%
Duplicated Renal Collecting System
10%
Single-center Experience
10%
Ureteral Stone
10%
Warm Ischemia Time
10%
Tumor
10%
Transobturator Tape
9%
Laparoscopic Cryoablation
9%
Multivariable
9%
Postoperative Outcomes
8%
Renal Mass
8%
Body Mass Index
8%
Robotic-assisted
8%
Success Rate
8%
Renal Preservation
8%
Cancer-specific Survival
8%
Auxiliary Method
8%
Prostate-specific Antigen
8%
Stone-free Rate
7%
Cryoablation
7%
Operative
7%
Male Patients
7%
Renal Tumor
7%
Overall Survival
7%
Suprapubic
7%
Non-associated
7%
Stone-free Status
7%
Renal Parenchyma
7%
Incision
7%
Major Complications
6%
Antegrade
6%
Surgical Technique
6%
RENAL Nephrometry Score
6%
Confidence Interval
6%
Robot-assisted Laparoscopic Radical Prostatectomy
6%
Calyceal
6%
Perineal Approach
6%
Step Techniques
6%
Surgeons
6%
Estimated Blood Loss
6%
Extracorporeal Shock Wave Lithotripsy
6%
Percutaneous Nephrolithotomy
6%
Clavien
6%
Renal Stone
6%
Renal Neoplasms
6%
Debridement
5%
Adult Male
5%
Operative Outcomes
5%
Volumetric Assessment
5%
Between-group
5%
Pathological Outcomes
5%
Laparoscopic Radical Prostatectomy
5%
Resection
5%
Histopathological Examination
5%
Stone Size
5%
Significant Predictors
5%
Consecutive Patients
5%
Overall Complications
5%
Laparoscopic Surgery
5%
Fluctuation Frequency
5%
Calculus
5%
Fournier's Gangrene
5%
Prostate Cancer Screening
5%
Colonic Diverticula
5%
Malignant Melanoma
5%
Robot-assisted Laparoscopic Partial Nephrectomy
5%
Treatment Results
5%
Child Age
5%
Pain Management
5%
Obesity
5%
Segmental Renal Artery
5%
Prior Abdominal Surgery
5%
Global Ischemia
5%
Renal Angiomyolipoma
5%
Tumor Necrosis Factor-α
5%
First-year Experience
5%
Medicine and Dentistry
Partial Nephrectomy
100%
Prostatectomy
37%
Kidney Tumour
32%
Neoplasm
32%
Clear Cell Renal Cell Carcinoma
27%
Glomerular Filtration Rate
26%
Kidney Function
23%
Cryoablation
15%
Body Mass Index
14%
Lithotripsy
13%
Surgical Anastomosis
13%
Ischemia
13%
Bladder Neck
12%
Ureter
12%
Heminephrectomy
10%
Bleeding
10%
Cystoscopy
10%
Pelvis
9%
Prostate Cancer
8%
Retroperitoneal Lymph Node Dissection
7%
Prostate Specific Antigen
7%
Incision
7%
Cancer Specific Survival
7%
Radical Nephrectomy
7%
Parenchyma
7%
Metastatic Carcinoma
7%
Kidney Stone
7%
Recurrent Disease
6%
Overall Survival
6%
Nephrectomy
6%
Fistula
6%
Histopathology
6%
Lower Urinary Tract Symptom
6%
Ureter Stone
6%
Percutaneous Nephrolithotomy
6%
Stone Formation
6%
Debridement
5%
Digestive System Surgery
5%
Charlson Comorbidity Index
5%
Surgical Margin
5%
Suture
5%
Postoperative Complication
5%
Laparoscopic Surgery
5%
Robot-Assisted Prostatectomy
5%
Creatinine
5%
Sarcoidosis
5%
Cytokine
5%
Urethroplasty
5%
Fournier Gangrene
5%
Meta-Analysis
5%
Nephroureterectomy
5%
Sarcomatoid
5%
Tumor Necrosis Factor
5%
Venous Thromboembolism
5%
Programmed Cell Death
5%
Endoscope
5%
Cadaver
5%
Living Donors
5%
Laparoendoscopic Single Site Surgery
5%
Fingertip
5%
Adrenalectomy
5%
Radioisotope Renography
5%
Bladder
5%
Kidney Allograft
5%
Tertiary Care
5%
Renal Artery
5%
Urolithiasis
5%
Melanoma
5%
Urogenital Fistula
5%
Angiomyolipoma
5%
Transperitoneal Robotic Partial Nephrectomy
5%
Medicare
5%
K-Complex
5%
Ureter Catheterization
5%
Diverticulum
5%
Polyp
5%
Spindle Cell
5%
Stress Incontinence
5%
Pneumoperitoneum
5%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
5%
Hyperoxaluria
5%
Cystectomy
5%
Doppler Ultrasound
5%
Microsurgery
5%
Elective Surgery
5%
Prospective Cohort Study
5%
Varicocelectomy
5%
COVID-19 Vaccination
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Doppler Flowmetry
5%
Odds Ratio
5%
Sepal
5%